Pharmacokinetics and Pharmacodynamics Practice Questions

Q: What is the mechanism of metabolism for alcohol, aspirin, and phenytoin at high doses?

Zero order kinetics. ***Zero order kinetics*** - This mechanism occurs when the **metabolic enzymes become saturated at high drug concentrations**, leading to a constant amount (not a constant percentage) of drug being eliminated per unit time. - Alcohol, aspirin, and phenytoin are examples of drugs that exhibit **saturable metabolism**, transitioning from first-order to zero-order kinetics at higher doses. *First pass kinetics* - This describes the **metabolism of a drug by the liver or gut wall enzymes before it reaches systemic circulation** after oral administration. - While relevant to the oral bioavailability of these drugs, it does not describe the specific mechanism of elimination at high doses. *First order kinetics* - In this mechanism, a **constant fraction or percentage of the drug is eliminated per unit of time**, meaning the rate of elimination is directly proportional to the drug concentration. - Most drugs follow first-order kinetics at therapeutic doses because metabolizing enzymes are not saturated. *Second order kinetics* - This is a **less common pharmacokinetic model** where the rate of elimination is proportional to the square of the drug concentration or involves two reactants. - It does not typically describe the common elimination patterns of most drugs, including alcohol, aspirin, and phenytoin.

Q: When two different chemicals act on two different receptors and their responses are opposite to each other on the same cell, this phenomenon is called?

Physiological antagonism. ***Physiological antagonism*** - This occurs when two drugs act on **different receptors** to produce **opposite physiological effects** within the same system or cell, effectively canceling each other out [1]. - A classic example is the opposing actions of **histamine** (causing bronchoconstriction) and **adrenaline** (causing bronchodilation) on the bronchi [1]. *Chemical antagonism* - This involves a direct **chemical interaction** between two drugs that results in the **inactivation of one or both** of them. - An example is the binding of **chelating agents** to heavy metals, forming an inert complex. *Reversible antagonism* - This describes antagonism where the antagonist binds to the receptor and can be **displaced by a higher concentration of the agonist**. - It does not specifically describe antagonists acting on different receptors or producing opposing physiological effects. *Competitive antagonism* - This occurs when an antagonist directly **competes with an agonist for the same binding site** on a receptor [1]. - The antagonist, while not producing a response itself, prevents the agonist from binding and activating the receptor.

Q: In the context of pharmacology, which plasma protein do acidic drugs primarily bind to?

Albumin. ***Albumin*** - **Albumin** is the most abundant plasma protein and has multiple binding sites for a wide range of drugs, particularly **acidic drugs**. - Its high concentration and diverse binding capabilities make it the primary transporter for many **lipophilic** and **anionic drugs**. *Globulin* - **Globulins** are a diverse group of proteins, some of which bind to drugs, but they primarily transport **hormones**, **metals**, and **vitamins**, not acidic drugs. - They are less significant for binding acidic drugs compared to albumin. *α1-acid glycoprotein* - **α1-acid glycoprotein** primarily binds to **basic drugs** due to its numerous acidic residues. - While it plays a crucial role in binding basic compounds, it has limited affinity for acidic drugs. *None of the options* - This option is incorrect because **albumin** is a well-established and significant plasma protein for binding acidic drugs. - Specific plasma proteins are known to bind different types of drugs, and for acidic drugs, albumin is the primary binder.

Q: Which of the following act through G protein coupled receptors?

Ach Muscarinic receptors. ***Ach Muscarinic receptors*** - All five **muscarinic acetylcholine receptors (M1-M5)** are **G protein-coupled receptors (GPCRs)** that mediate the parasympathetic nervous system's effects. - Activation of these receptors leads to downstream signaling through various G proteins, influencing cellular functions like heart rate and smooth muscle contraction. *Insulin receptors* - Insulin receptors are **receptor tyrosine kinases (RTKs)**, not GPCRs. - Upon insulin binding, they undergo autophosphorylation and activate intracellular signaling cascades involving **IRS proteins**, leading to glucose uptake. *Ach Nicotinic receptors* - Nicotinic acetylcholine receptors are **ligand-gated ion channels**, not GPCRs. - They open an ion pore in response to acetylcholine binding, allowing ions like sodium to flow through, resulting in rapid depolarization. *GABA-A receptors* - GABA-A receptors are also **ligand-gated ion channels**, specifically anion channels that are permeable to chloride ions. - When GABA binds, they open, allowing chloride influx, which typically hyperpolarizes the neuron and inhibits neural activity.

Q: Which of the following drugs is known to have low first pass metabolism?

Theophylline. ***Theophylline*** - **Theophylline** exhibits **low first-pass metabolism**, meaning a significant portion of the orally administered drug reaches systemic circulation unchanged. - This characteristic contributes to its relatively **high bioavailability** when given orally. *Lidocaine* - **Lidocaine** undergoes extensive **first-pass metabolism** in the liver, leading to very low oral bioavailability. - Due to this, it is typically administered **parenterally** (e.g., intravenously or topically) to achieve therapeutic concentrations. *Propranolol* - **Propranolol** is known for its significant **first-pass metabolism**, which results in a much lower bioavailability after oral administration compared to intravenous. - This extensive metabolism necessitates higher oral doses to achieve the same therapeutic effect as parenteral administration. *Morphine* - **Morphine** also undergoes substantial **first-pass metabolism** in the liver, where it is primarily glucuronidated. - This leads to a lower oral bioavailability compared to other routes of administration and contributes to a higher oral dose requirement.

Q: Which route of administration undergoes the maximum first pass metabolism?

Oral. ***Oral*** - Drugs administered orally are absorbed from the **gastrointestinal tract** and transported via the **portal vein** directly to the liver, where they undergo significant **first-pass metabolism** before reaching systemic circulation. - This hepatic metabolism can drastically reduce the **bioavailability** of the drug, requiring higher doses or alternative administration routes. *Intra-arterial* - This route delivers drugs directly into an **artery** supplying a target tissue or organ, largely bypassing systemic circulation and initial hepatic metabolism. - It is used for localized effects, such as **chemotherapy** for specific tumors, minimizing systemic exposure. *Rectal* - While a portion of rectally administered drugs may bypass the portal circulation by entering the **inferior and middle rectal veins**, a significant amount can still be absorbed into the superior rectal vein, which drains into the portal system. - This means rectal administration offers only **partial avoidance** of first-pass metabolism, making it less complete than IV or intra-arterial routes for bypassing the liver altogether. *Intravenous* - Drugs administered intravenously are delivered directly into the **systemic circulation**, completely bypassing the gastrointestinal tract and the liver's first-pass metabolism. - This route ensures **100% bioavailability** and rapid onset of action, as the drug immediately reaches its target.

Q: What is the effect of adding epinephrine to lignocaine (a local anesthetic)?

Decreases absorption of local anesthetic. ***Decreases absorption of local anesthetic*** - Epinephrine causes **vasoconstriction** at the site of injection, which reduces the rate at which the local anesthetic is absorbed into the systemic circulation. - This slower absorption leads to a **higher concentration of the anesthetic** at the nerve fibers, prolonging its effect and reducing systemic toxicity. - This is the primary mechanism by which epinephrine enhances local anesthetic efficacy. *Increases distribution of local anesthetic* - The primary effect of epinephrine is to **localize the anesthetic** by reducing its systemic distribution. - This localization is achieved through **vasoconstriction**, which keeps the drug at the desired site rather than allowing it to distribute widely. *Decreases duration of local anesthetic* - By slowing absorption, epinephrine effectively **increases the duration of action** of the local anesthetic. - The anesthetic remains at the site of action for a longer period, providing **extended pain relief**. *Increases metabolism of local anesthetic* - Epinephrine does not directly affect the **metabolic rate** of local anesthetics. - The primary mechanism of metabolism for amides like lignocaine is in the **liver** by cytochrome P450 enzymes.

Q: Which of the following is not a phase I reaction?

Conjugation. ***Conjugation*** - **Conjugation** reactions are characteristic of **phase II metabolism**, where a polar molecule is added to the drug to increase its water solubility and facilitate excretion. - This process is distinct from phase I reactions which primarily involve exposure of functional groups. *Oxidation* - **Oxidation** is a primary **phase I metabolic reaction**, often mediated by cytochrome P450 enzymes. - It introduces or exposes a polar functional group on the drug molecule. *Reduction* - **Reduction** is another key **phase I metabolic reaction**, which involves the gain of electrons by a drug molecule. - This reaction can alter the drug's activity or prepare it for further metabolism. *Hydrolysis* - **Hydrolysis** is a **phase I metabolic reaction** that involves the cleavage of a chemical bond by water. - This process typically breaks down esters and amides, exposing functional groups.

Q: Which of the following best demonstrates the variability in drug responsiveness among individuals?

Quantal Dose Response Curve. ***Quantal Dose Response Curve*** - A **quantal dose-response curve** plots the percentage of individuals exhibiting a discrete, all-or-none effect against the log dose of a drug. - This curve directly illustrates the **variability in drug responsiveness** within a population by showing the range of doses required to produce a specific effect in different individuals. *Efficacy* - **Efficacy** refers to the maximum effect a drug can produce, regardless of the dose. - While efficacy is an important pharmacological parameter, it describes the drug's overall therapeutic potential, not the **individual variability** in response. *Potency* - **Potency** is a measure of the amount of drug needed to produce an effect of given intensity. - It relates to the absolute dose required for a particular effect but does not directly demonstrate the **inter-individual differences** in biological response. *Graded Dose Response Curve* - A **graded dose-response curve** depicts the relationship between the dose of a drug and the **magnitude of the effect** in a **single biological unit** (e.g., an individual, a tissue, or a cell). - This curve reflects the relationship between drug concentration and effect intensity, but not the **variability in response among different individuals** in a population.

Question 1

What is the mechanism of metabolism for alcohol, aspirin, and phenytoin at high doses?

Accepted Answer

Zero order kinetics

Answer

First pass kinetics

Answer

First order kinetics

Answer

Second order kinetics

Question 2

When two different chemicals act on two different receptors and their responses are opposite to each other on the same cell, this phenomenon is called?

Accepted Answer

Physiological antagonism

Answer

Chemical antagonism

Answer

Reversible antagonism

Answer

Competitive antagonism

Question 3

In the context of pharmacology, which plasma protein do acidic drugs primarily bind to?

Accepted Answer

Albumin

Answer

Globulin

Answer

α1-acid glycoprotein

Answer

None of the options

Question 4

Which of the following act through G protein coupled receptors?

Accepted Answer

Ach Muscarinic receptors

Answer

Insulin receptors

Answer

Ach Nicotinic receptors

Answer

GABA-A receptors

Question 5

Which of the following drugs is known to have low first pass metabolism?

Accepted Answer

Theophylline

Answer

Lidocaine

Answer

Propranolol

Answer

Morphine

Question 6

Which route of administration undergoes the maximum first pass metabolism?

Accepted Answer

Oral

Answer

Intra-arterial

Answer

Rectal

Answer

Intravenous

Question 7

What is the effect of adding epinephrine to lignocaine (a local anesthetic)?

Accepted Answer

Decreases absorption of local anesthetic

Answer

Increases distribution of local anesthetic

Answer

Decreases duration of local anesthetic

Answer

Increases metabolism of local anesthetic

Question 8

Which of the following is not a phase I reaction?

Accepted Answer

Conjugation

Answer

Oxidation

Answer

Reduction

Answer

Hydrolysis

Question 9

Which of the following best demonstrates the variability in drug responsiveness among individuals?

Accepted Answer

Quantal Dose Response Curve

Answer

Potency

Answer

Efficacy

Answer

Graded Dose Response Curve

Question 10

Drug X has an affinity for albumin, while drug Y has 150 times greater affinity. Which of the following statements is MOST accurate?

Accepted Answer

The free concentration of drug X in blood is higher, facilitating tissue distribution.

Answer

Drug X will be more available in tissues

Answer

Drug Y will be less available in tissues

Answer

Toxicity of drug Y may be influenced by multiple factors, not just its binding.

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?